2024-2027. CARUSO: Cooperation and transfer to valorize the natural resources and thermal waters of the territory POCTEFA: development of cosmetic products to improve the skin microbiota
2023-2026. DAIRYBIOHEALTH. Application of new technologies in the processing of dairy by-products to obtain bioactive fractions for the improvement of intestinal health
2023-2026. HI2BIO. Valorisation of industrial wastewater for the generation of biological hydrogen
ALIPAT. Effect of Technological Processing of Food on Digestive and Allergic Pathologies. The Research group is dedicated to the development of techniques to detect the presence in foods of proteins that cause food allergies. It has worked on test development projects for the detection of certain allergens (milk, egg, peanut, soy, almond or hazelnut)
2022. Characterization of postbiotics derived from dairy products fermented with kefir cultures
2022. Immune regulation through short-chain fatty acids: effect on Natural Killer cells
2021-2023. Heterometallic Complexes as Antiproliferative Agents: Moving Towards New Drugs Against Cancer
2021-2023. Canine idiopathic epilepsy: cognitive-behavioural alterations, genetic basis, biomarkers and involvement of the intestinal microbiota in its development
2020-2021. Biological properties of dairy by-products: modulation of the microbiota and the intestinal immune system
2019. Effect of short chain fatty acids from the microbiota on the serotoninergic system
2018-2019. Inflamasome in amyotrophic lateral sclerosis: inhibition of NLRP3 inflama some in an animal model of als
2018-2021. Effect of technological treatments on the activity of proteins and dairy fractions on intestinal functionality: potential for its application in functional foods
2018-2020. Platelets as biomarkers in colorectal cancer: study of the transcryptome, proteome and markers of platelet activation
2018-2020. Strategic Research Line "Intestinal microbiota in nutrition and health"
2017. Study of the influence of the microbiota and the toll-type receptors (TLR) in the synthesis and motor response of H2S in the mouse colon
2016-2017. Role of the microbiota in gastrointestinal motor alterations and pain associated with colitis. Involvement of serotonin and serine-protease granzima A.
2015. Emerging group: pathophysiology regulation of gastrointestinal motility
2015. Intestinal microbiota host interaction: molecular mechanisms involved in homeostasis and intestine inflammatory processes
2014. Host interaction study of the role of toll-like receptors (TLR) and the serotoninergic system in intestinal alterations produced in mice treated with antibiotics
201-2013. Diagnosis and identification of therapeutic targets in chronic visceral pain: focus on lipid mediators and the receptors of the transient receptor potential family
2011. Diagnosis and identification of physiopathological pathways involved in digestive disorders
2010. Intracellular mechanisms involved in the actions of lps on gastrointestinal motility
2009. Role of serotonin in intestinal epithelial barrier function: alteration mediated by lps
2008. Serotoninergic response in the intestinal epithelium to acute and chronic infectious-inflammatory action
2006-2009. Study of the physiopathological pathways involved in gastrointestinal motor disorders induced by infectious agents
2006-2016. Consolidated group: gastrointestinal pathophysiology
2003-2006. Participation of nitric oxide and free radicals in gastrointestinal motor disorders induced by infectious agents